An interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2) - development, feasibility, and pilot testing of a complex intervention

IntroductionDespite the lack of high-quality evidence regarding its long-term effectiveness, intravenous corticosteroid therapy is recommended as the standard treatment of acute multiple sclerosis relapses in Germany. High financial expenses and the equivalent effectiveness of oral corticosteroid th...

Full description

Bibliographic Details
Main Authors: Lisa Wenzel, Christoph Heesen, Julia Peper, Kristina Grentzenberg, Edeltraud Faßhauer, Jutta Scheiderbauer, Frithjof Thale, Björn Meyer, Sascha Köpke, Anne Christin Rahn
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.914814/full